This innovative device delivers high doses of chemotherapy directly to the hepatic artery, significantly improving drug concentration in liver tumors while minimizing systemic side effects.
Click below learn more about our personalized, multidisciplinary care options.
We focus the expertise of the region’s most advanced gastrointestinal cancer team on delivering only the best results. Our nationally recognized cancer subspecialists offer you access to standard therapies as well as the latest treatments and leading-edge clinical trials.
To schedule an appointment, please call the UC Gastrointestinal Cancer team at 513-585-UCCC.
The hepatic artery infusion pump is an advanced treatment option for patients with liver cancer, colorectal liver metastases, and other hepatic metastases. This innovative device delivers high doses of chemotherapy directly to the hepatic artery, significantly improving drug concentration in liver tumors while minimizing systemic side effects.
By targeting the source of the disease, the hepatic artery infusion pump offers a more effective approach to managing liver-related cancers, providing hope for patients who may not be candidates for traditional treatments.
The hepatic artery infusion pump (HAIP) is a specialized device used to deliver chemotherapy directly to the liver, targeting liver metastases and primary liver cancer. This approach is known as regional chemotherapy, which differs significantly from systemic chemotherapy that affects the entire body.
Targeted Delivery: The HAIP administers high doses of chemotherapy directly into the hepatic artery, which supplies blood to liver tumors. This localized treatment increases drug concentration at the tumor site while reducing exposure to the rest of the body.
Improved Efficacy: By concentrating the chemotherapy where it is needed most, the HAIP can enhance treatment effectiveness, potentially leading to better outcomes for patients with liver cancer.
Minimized Side Effects: Since the chemotherapy is delivered directly to the liver, patients often experience fewer systemic side effects compared to traditional chemotherapy methods.
This innovative treatment option provides a more focused approach to managing liver cancer, offering hope for patients who may not be candidates for surgical intervention.
The hepatic artery infusion pump is designed to deliver chemotherapy directly to the liver, enhancing treatment effectiveness for liver tumors. This targeted approach allows for higher concentrations of medication to reach the tumor while minimizing exposure to the rest of the body.
Direct Delivery: The pump administers chemotherapy through a catheter placed in the hepatic artery, which supplies blood to the liver. This method ensures that the drug is concentrated where it is needed most.
Pump Implantation: The pump is surgically implanted under the skin, typically in the abdomen. This allows for easy access and management of the infusion process.
Surgical Procedure: A catheter is inserted into the hepatic artery during a minimally invasive procedure. This catheter is connected to the pump, allowing for continuous or intermittent delivery of chemotherapy.
Monitoring and Maintenance: After implantation, healthcare providers monitor the pump and catheter to ensure proper function and to manage any potential complications.
This innovative system not only improves drug delivery but also enhances patient comfort by reducing systemic side effects associated with traditional chemotherapy methods.
The hepatic artery infusion pump is an effective treatment option for several conditions affecting the liver. This targeted approach is particularly beneficial for patients who may not be candidates for surgical resection.
Colorectal Liver Metastases: Cancer that has spread from the colon or rectum to the liver.
Bile Duct Cancer: Also known as cholangiocarcinoma, this cancer affects the bile ducts and can be challenging to treat.
Intrahepatic Cholangiocarcinoma: A type of bile duct cancer that occurs within the liver.
Unresectable Colorectal Liver Metastases: Cases where tumors cannot be surgically removed due to their size or location.
Localized Treatment: By delivering chemotherapy directly to the liver, the pump increases drug concentration at the tumor site.
Reduced Systemic Side Effects: This method minimizes exposure to the rest of the body, leading to fewer side effects compared to traditional systemic chemotherapy.
Improved Outcomes: For patients with advanced liver cancer or metastases, this therapy can enhance treatment effectiveness and potentially prolong survival.
This targeted approach offers hope for patients facing challenging diagnoses, providing a pathway to manage their conditions more effectively.
The hepatic artery infusion (HAI) surgery is a specialized procedure that involves the implantation of a pump to deliver chemotherapy directly to the liver. Here’s what patients can expect during the process:
The procedure is performed by a surgical oncologist, who specializes in cancer treatment.
A thorough evaluation is conducted to determine the best approach for each patient.
Anesthesia: Patients receive general anesthesia to ensure comfort during the procedure.
Incision: A small incision is made in the abdomen to access the hepatic artery.
Catheter Placement: A catheter is inserted into the hepatic artery, allowing for targeted delivery of chemotherapy.
Pump Implantation: The infusion pump is implanted under the skin, typically in the abdomen, where it can be easily accessed for maintenance.
Closure: The incision is closed with sutures or staples.
Patients are monitored in a recovery area before being moved to a hospital room.
Pain management and care instructions are provided to ensure a smooth recovery.
Follow-up appointments are scheduled to assess the pump function and overall health.
The pump requires regular maintenance, including refilling with chemotherapy and monitoring for any complications.
Patients will receive guidance on how to care for the pump and recognize any signs of issues.
This procedure is designed to maximize the effectiveness of chemotherapy while minimizing systemic side effects, allowing patients to receive targeted treatment for liver cancer and metastases.
Hepatic artery infusion pump therapy offers several significant benefits for patients with liver tumors. By delivering chemotherapy directly to the hepatic artery, this method enhances drug concentration at the tumor site while minimizing systemic exposure.
Targeted Treatment: The pump allows for high doses of chemotherapy to be administered directly to the liver tumors, increasing effectiveness.
Localized Action: Concentrated chemotherapy reduces the amount of drug needed, which can lead to fewer side effects.
Less Impact on Healthy Tissue: By focusing treatment on the liver, patients experience fewer adverse effects compared to traditional systemic chemotherapy.
Improved Tolerance: Patients often tolerate the treatment better, leading to an enhanced quality of life during therapy.
Potential for Curative Resection: In select cases, effective treatment with the pump may make previously unresectable tumors operable.
Longer Survival Rates: Studies indicate that patients receiving hepatic artery infusion therapy may experience improved survival rates compared to those undergoing systemic chemotherapy alone.
These advantages make the hepatic artery infusion pump a valuable option for patients facing liver cancer and other hepatic metastases.
The hepatic artery infusion pump (HAIP) offers a distinct approach compared to traditional chemotherapy, systemic therapy, and surgical resection.
Targeted Delivery: HAIP delivers chemotherapy directly to the liver, enhancing drug concentration at the tumor site while reducing systemic exposure.
Side Effects: Patients often experience fewer systemic side effects with HAIP compared to traditional chemotherapy, which affects the entire body.
Efficacy: HAIP can be more effective for liver tumors, as it bypasses the liver's first-pass metabolism, allowing higher drug levels to reach the tumor.
Patient Suitability: Some patients with liver metastases may not respond well to systemic therapy, making HAIP a more suitable option.
Non-Surgical Candidates: HAIP is beneficial for patients who are not candidates for surgical resection due to the extent of disease or other health factors.
Palliative Care: For patients with unresectable tumors, HAIP can provide palliative benefits, improving quality of life and potentially extending survival.
By understanding these differences, patients can make informed decisions about their treatment options based on their specific conditions and needs.
While the hepatic artery infusion pump offers significant benefits, there are potential risks and complications associated with its use. Understanding these risks can help patients make informed decisions about their treatment.
Blood Vessel Issues: The catheter may cause damage to the blood vessels, leading to complications such as thrombosis or stenosis.
Fluid Buildup: Patients may experience fluid accumulation around the pump or in the abdominal cavity, which can require drainage.
Catheter Blockages: The catheter can become blocked, preventing effective delivery of chemotherapy. Regular monitoring is essential to address this issue promptly.
The medical oncology team plays a crucial role in managing these risks. They conduct regular assessments and imaging studies to monitor the pump's function and the patient's overall health. If complications arise, the team is prepared to intervene quickly, ensuring that patients receive the necessary care to minimize risks and maintain treatment effectiveness.
Patients can expect significant benefits from hepatic artery infusion pump therapy. This treatment often leads to improved survival rates and a positive response in tumor size reduction. Many patients report enhanced quality of life due to targeted chemotherapy, which minimizes systemic side effects.
After the implantation of the pump, recovery typically involves a short hospital stay. Patients may experience some discomfort at the catheter site, but this usually resolves quickly. Regular follow-up appointments are essential for monitoring the pump's function and overall health.
Long-term systemic treatment considerations include ongoing assessments to evaluate tumor response and adjust therapy as needed. With proper management, many patients can maintain an active lifestyle while receiving treatment.
Hepatic artery infusion pump therapy has shown remarkable success in treating various liver cancers. Here are a few patient stories that highlight its effectiveness:
Trisha’s Story: For Trisha, learning about the revolutionary hepatic artery infusion pump began a rigorous yet hopeful journey. She made the five-hour drive from Tennessee to Cincinnati every two weeks for treatment. The device delivered chemotherapy directly to her liver tumors, enabling her body to fight back against the cancer that once seemed unstoppable.
At UC Health, we lead the region in scientific discoveries and embrace a spirit of purpose – offering our patients and their families something beyond everyday healthcare. At UC Health, we offer hope.